Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Activation of central melanocortin pathways by fenfluramine.

Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, Holstege H, Lee CE, Cone RD, Elmquist JK.

Science. 2002 Jul 26;297(5581):609-11.

2.
3.

The appetite suppressant d-fenfluramine reduces water intake, but not food intake, in activity-based anorexia.

Hillebrand JJ, Heinsbroek AC, Kas MJ, Adan RA.

J Mol Endocrinol. 2006 Feb;36(1):153-62.

4.

Central serotonin and melanocortin pathways regulating energy homeostasis.

Heisler LK, Cowley MA, Kishi T, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro J, Zigman JM, Cone RD, Elmquist JK.

Ann N Y Acad Sci. 2003 Jun;994:169-74. Review.

PMID:
12851313
6.

Electrophysiological actions of peripheral hormones on melanocortin neurons.

Cowley MA, Cone R, Enriori P, Louiselle I, Williams SM, Evans AE.

Ann N Y Acad Sci. 2003 Jun;994:175-86. Review.

PMID:
12851314
7.

A serotonin and melanocortin circuit mediates D-fenfluramine anorexia.

Xu Y, Jones JE, Lauzon DA, Anderson JG, Balthasar N, Heisler LK, Zinn AR, Lowell BB, Elmquist JK.

J Neurosci. 2010 Nov 3;30(44):14630-4. doi: 10.1523/JNEUROSCI.5412-09.2010.

8.
9.

Melanocortin signaling and anorexia in chronic disease states.

Wisse BE, Schwartz MW, Cummings DE.

Ann N Y Acad Sci. 2003 Jun;994:275-81. Review.

PMID:
12851326
10.

Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat.

Clifton PG, Lee MD, Dourish CT.

Psychopharmacology (Berl). 2000 Oct;152(3):256-67.

PMID:
11105935
11.
13.

VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting.

Hahm S, Fekete C, Mizuno TM, Windsor J, Yan H, Boozer CN, Lee C, Elmquist JK, Lechan RM, Mobbs CV, Salton SR.

J Neurosci. 2002 Aug 15;22(16):6929-38.

15.

[Relevance of the melanocortinergic system for body weight regulation].

Raab M, Hinney A, Grassl W, Remschmidt H, Hebebrand J.

Dtsch Med Wochenschr. 2003 Feb 28;128(9):447-52. German. No abstract available.

PMID:
12612858
16.

Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Halford JC, Harrold JA, Boyland EJ, Lawton CL, Blundell JE.

Drugs. 2007;67(1):27-55. Review.

PMID:
17209663
17.

Contribution of caudal brainstem to d-fenfluramine anorexia.

Grill HJ, Donahey JC, King L, Kaplan JM.

Psychopharmacology (Berl). 1997 Apr;130(4):375-81.

PMID:
9160854
19.

Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system.

Garattini S, Mennini T, Bendotti C, Invernizzi R, Samanin R.

Appetite. 1986;7 Suppl:15-38. Review.

PMID:
2427023
20.

PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY.

Ann N Y Acad Sci. 2003 Jun;994:96-102.

PMID:
12851303
Items per page

Supplemental Content

Support Center